1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. France >
  5. Pharma Omnium Acquires CellVir SAS

M&A Deal Summary

Pharma Omnium Acquires CellVir SAS

On June 1, 2010, Pharma Omnium acquired life science company CellVir SAS

Acquisition Highlights
  • This is Pharma Omnium’s 1st transaction in the Life Science sector.
  • This is Pharma Omnium’s 1st transaction in France.

M&A Deal Summary
Date 2010-06-01
Target CellVir SAS
Sector Life Science
Buyer(s) Pharma Omnium
Deal Type Add-on Acquisition

Target

CellVir SAS

Evry, France
CellVir SAS is a biotech company. CellVir is a specialist in innovative treatments for viruses, particularly the AIDS virus.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Pharma Omnium

Paris, France
Category Company
Sector Life Science
DESCRIPTION

Pharma Omnium is a laboratory specialising in mature, widely-known pharmaceutical products that have strong potential but are no longer heavily promoted. The laboratory has an anti-infective pharmaceutical research activity with a virology division and a bacteriology division. Pharma Omnium is based in Paris, France.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: France M&A 1 of 1
Year: 2010 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal